Jennifer H. Mak - 01 Dec 2025 Form 4 Insider Report for AXON ENTERPRISE, INC. (AXON)

Role
Chief Accounting Officer
Signature
/s/ Jennifer H. Mak by Isaiah Fields, Attorney-in-Fact
Issuer symbol
AXON
Transactions as of
01 Dec 2025
Net transactions value
-$1,186,710
Form type
4
Filing time
03 Dec 2025, 17:46:52 UTC
Previous filing
17 Nov 2025
Next filing
08 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mak Jennifer H Chief Accounting Officer 17800 N 85TH ST, SCOTTSDALE /s/ Jennifer H. Mak by Isaiah Fields, Attorney-in-Fact 03 Dec 2025 0001673075

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXON Common Stock Tax liability $45,912 -85 -0.51% $540.14 16,547 01 Dec 2025 Direct F1
transaction AXON Common Stock Tax liability $1,101,079 -2,065 -12% $533.21 14,482 01 Dec 2025 Direct F2
transaction AXON Common Stock Sale $39,720 -74 -0.51% $536.75 14,408 03 Dec 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Securities disposed represent securities withheld to settle the reporting person's tax liability resulting from the vesting of restricted stock units.
F2 Securities disposed represent securities withheld to settle the reporting person's tax liability arising out of the vesting of the second tranche of restricted stock units granted pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions were determined to have been certified by the issuer's Compensation Committee on March 24, 2025.
F3 This sale, effected pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, consisted of shares issued upon the settlement of vested restricted stock units.